Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Oculis Holding AG Ordinary shares
OCS | US
26.44
USD-0.33
-1.23%
OCS | US
Loading StockChartView...
About Oculis Holding AG Ordinary shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
26.44
Open
26.77
High
27.32
Low
26.04
Oculis Holding AG a clinical-stage biopharmaceutical company develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01 a topical dexamethasone formulation which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02 a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca or dry eye disease; and OCS-05 a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders such as glaucoma diabetic retinopathy geographic atrophy and neurotrophic keratitis. The company is based in Zug Switzerland.
View LessOCS | US
Risk
42.5
Sharpe
1.07
Luna's Score
48/100
Recommendation
Hold
Luna says (OCS | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
38.6%1 month
42.5%3 months
42.1%6 months
44.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.49
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-3.47
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-62.84M
MarketCap
1.10B
MarketCap(USD)
1.10B
Div. yield
-
Op. margin
-9.18K
Erngs. growth
-
Rev. growth
-2.00
Ret. on equity
-58.12
Short ratio
0.61
Short perc.
0.06
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
3.27
Range1M
4.99
Range3M
6.66
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.02
Price X volume
8.18M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.47 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.49 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 42.13 | 72.80 | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 1.10B | 3.66B | Emerging |
